|
|
|||
|
||||
OverviewThe eLIFT and FIB-4 scores offered the best diagnostic performance, with high sensitivity and specificity for detecting advanced fibrosis and cirrhosis. eLIFT showed a remarkable ability to predict advanced stages of fibrosis thanks to the integration of several parameters. APRI and King Score showed good results, but with lower specificity for advanced stages. These non-invasive serum biomarkers, in particular eLIFT and FIB-4, are proving to be reliable alternatives to invasive methods, enabling faster, more accessible and less costly diagnosis, particularly in resource-limited settings. Full Product DetailsAuthor: Imen Akkari , Hamza Sboui , Ameni HassinePublisher: Our Knowledge Publishing Imprint: Our Knowledge Publishing Dimensions: Width: 15.20cm , Height: 0.30cm , Length: 22.90cm Weight: 0.082kg ISBN: 9786208831981ISBN 10: 6208831989 Pages: 52 Publication Date: 04 July 2025 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Available To Order We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||